Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03469609
Other study ID # MUC-FIRE
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 18, 2018
Est. completion date November 2024

Study information

Verified date December 2023
Source University of Leipzig
Contact Martin Lacher, Prof. Dr.
Phone +49-341-97
Email muc-fire-leipzig@medizin.uni-leipzig.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to demonstrate that mucous fistula refeeding between enterostomy creation and enterostomy closure reduces the time to full enteral feeds after enterostomy closure compared to standard of care.


Description:

Enterostomies in children may be created for different reasons. During the presence of an enterostomy the regular stool transfer is interrupted as the distal part of the bowel (the part following the enterostomy) does not participate in the circulation of stool. Therefore it does not contribute to the resorption of enteral contents. As a consequence these children need additional parenteral nutrition. Due to the negative side-effects of parenteral nutrition all patients should return to enteral nutrition as soon as possible. Consequently, many pediatric surgical centers worldwide routinely perform mucous fistula refeeding (MFR) into the former unused bowel after enterostomy creation because case reports and retrospective analyses show low complication rates and faster postoperative weight gain. Several providers, however, shy away from this approach because to date there is still no high quality evidence for the benefit of this Treatment.The aim of this study is to assess the effects of mucous fistula refeeding in a randomized, prospective trial. We hypothesize that MFR between enterostomy creation and enterostomy closure reduces the time to full enteral feeds after enterostomy closure compared to the group without refilling. Moreover, the side effects of parenteral nutrition may be reduced and the postoperative hospital care of infants undergoing ostomy closure shortened.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date November 2024
Est. primary completion date November 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 12 Months
Eligibility Inclusion Criteria: 1. Infants < 366 days, 2. Ileostomy / Jejunostomy, 3. double loop enterostomies and split enterostomies (with mucous fistula) 4. Signed written informed consent obtained by parents/legal guardians and willingness of parents/legal guardians to comply with treatment and follow-up procedures of their child Exclusion Criteria: 1. resection of ileocecal valve, 2. colostomy, 3. small bowel atresia, 4. multiple ostomies (more than just an enterostomy and a mucous fistula), 5. chromosomal abnormalities (if known at the time of randomization), 6. Hirschsprung's disease, 7. participation in another drug-intervention study 8. Intestinal perforation due to a hemodynamic heart defect

Study Design


Related Conditions & MeSH terms


Intervention

Other:
mucous fistula refeeding
Transfer of infants' own stool

Locations

Country Name City State
Austria Universitätsklinik für Kinder- und Jugendchirurgie Graz
Austria Universitätsklinik für Kinder- und Jugendheilkunde Wien
Germany University Hospital Augsburg, Clinic for Pediatric Surgery Augsburg
Germany Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Kinderchirurgie Dresden Sachsen
Germany Zentrum der Chirurgie, Klinik für Kinderchirurgie Frankfurt Hessen
Germany Hamburg [University Hospital Hamburg Eppendorf/UKE & Altonaer Kinderkrankenhaus/AKK] Hamburg
Germany Auf der Bult, Kinder- und Jugendkrankenhaus, Kinderchirurgie und Kinderurologie Hannover Niedersachsen
Germany Hannover Medical School, Clinic for Pediatric Surgery Hannover Niedersachsen
Germany University of Leipzig Leipzig Sachsen
Germany Universitätsmedizin Mainz, Klinik und Poliklinik für Kinderchirurgie Mainz Rheinland-Pfalz
Germany University Hospital Marburg, Clinic for Pediatric Surgery Marburg
Germany Städtisches Klinikum München GmbH/ Klinikum Schwabing München Bayern
Germany Universitätsklinik für Kinder- und Jugendmedizin Tübingen Tübingen Baden-Württemberg
Germany Marien Hospital Witten, Ruhr-University Bochum, Department of Pediatric Surgery Witten Nordrhein-Westfalen
Netherlands Amsterdam University Medical Centers Amsterdam
Netherlands Erasmus University Medical Center Rotterdam Rotterdam

Sponsors (3)

Lead Sponsor Collaborator
University of Leipzig German Research Foundation, Hannover Medical School

Countries where clinical trial is conducted

Austria,  Germany,  Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to full enteral feeds (hours) Time to full feeds (hours), defined as time to actual enteral intake of the age-dependent caloric requirements per day (defined as 90 or 120kcal/kg/24h) for at least 24 hours and a concomitant reduction of parenteral fluids to <20ml/kg/24h.
The nutrition aim is 120 kcal/kg/24h for premature infants with a birth weight < 1000g or premature infants with a birth weight = 1000g and mother's gestation week at birth before 37+0.
The nutrition aim is 90 kcal/kg/24h for born mature infants, mother's gestation week at birth at least 37+0.
week 4 to week 12 daily
Secondary Time to first bowel movement Cleaning and changing of infants diapers will be performed according to a fixed schedule in order to uniformly document the time to first bowel movement Week 4 to week 12 daily
Secondary Thriving Measurement of body weight Week 1 to week 12 daily; follow-up (month 3, 6, 12)
Secondary Z-Score (standard deviation score) Measurement of weight [weight for age, World Health Organization (WHO)] Week 1 to week 12 daily, follow-up (month 3, 6, 12)
Secondary Number of days of postoperative total parenteral nutrition (TPN) Calculation of days of postoperative TPN starts on the day of operation and ends on the day of full enteral nutrition Week 2 to week 12 daily, follow-up (month 3, 6, 12)
Secondary Laboratory parameter indicating cholestasis Measurement of conjugated Bilirubin (µmol/l) Week 1 to week 12 daily, follow-up (month 3)
Secondary Assessment of adverse events (AEs) Adverse events will be collected by the investigator either based on the information provided spontaneously by the parents of patient or evaluated by non-suggestive questions. Week 1 to week 12 daily, follow-up (month 3, 6, 12)
Secondary Assessment of serious adverse events (SAEs) Adverse events will be collected by the investigator either based on the information provided spontaneously by the parents of patient or evaluated by non-suggestive questions. Week 1 to week 12 daily, follow-up (month 3, 6, 12)
Secondary Postoperative weight gain (g/d) Weight gain during the subsequent 5 days after reaching the primary endpoint following enterostomy closure week 4 to week 12
Secondary Central venous line (CVL) duration (days) and number of CVL infections (definition of infection: Neo-Kiss Guidelines) Week 1 to week 12
Secondary hospitalisation Length of hospital stay (days) week 1 to week 12
Secondary jump in caliber Estimated ratio of the diameter of the two bowel loops which are anastomosed. week 5
Secondary Sodium resorption Sodium in Urine (mmol/l) Week 1 to week 12 daily, follow-up (month 3)
Secondary Status of liver enzymes Gamma-Glutamyltransferase (GGT) , Alanine-Aminotransferase (ALT) , Aspartate-Aminotransferase (AST) (µkat/l) Week 1 to week 12 daily, follow-up (month 3)
Secondary Laboratory parameters Haemoglobin (g/dl) Week 1 to week 12 daily, follow-up (month 3)
Secondary Time to full volume intake per day (in hours) Time to full age-dependent volume intake per day (defined as 150ml/kg/24h for premature infants and 120ml/kg/24h for mature born infants as well as corrected mature infants) (in hours).
The volume aim is 150 ml/kg/24h for premature infants with a birth weight < 1000g or premature infants with a birth weight = 1000g and mother's gestation week at birth before 37+0.
The volume aim is 120 ml/kg/24h for born mature infants, mother's gestation week at birth at least 37+0.
week 4 to week 12 daily
See also
  Status Clinical Trial Phase
Recruiting NCT03572673 - Study to Evaluate the Performance of a New 2-piece Ostomy Appliance vs. Flexima® 3S in Patients With Enterostomy N/A
Completed NCT02507726 - Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy N/A
Completed NCT04966286 - The Effectiveness of Applying Multimedia on Self-Care and Quality of Life in Patient With Enterostomy N/A
Completed NCT02811926 - Incidence and Risk Factors of Parastomal Bulging in Patients With Ileostomy or Colostomy N/A
Active, not recruiting NCT06392646 - Construction and Validation of a Postoperative Self-management Education Program for Elderly Patients With Enterostomies N/A
Completed NCT02713776 - Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment Phase 2
Completed NCT02812095 - Efficacy and Safety of Refeeding in Preterm Infants With Enterostomy N/A
Recruiting NCT05373888 - Safety and Performance of Flexima®/Softima® Stoma Appliances in Enterostomy Patients